ubiquinone and ethylmethylhydroxypyridine-succinate

ubiquinone has been researched along with ethylmethylhydroxypyridine-succinate* in 1 studies

Other Studies

1 other study(ies) available for ubiquinone and ethylmethylhydroxypyridine-succinate

Article	Year
[COMPARATIVE CARDIOPROTECTIVE EFFICACY OF COENZYME Q10 AND MEXICOR IN EXPERIMENTAL MODEL OF MYOCARDIAL INFARCTION IN RATS]. Eksperimental'naia i klinicheskaia farmakologiia, 2015, Volume: 78, Issue:6 Cardioprotective efficacy of coenzyme Q10 (CoQ10, ubidecarenone) and mexicor were evaluated on the 21st day of experimental myocardial infarction in Wistar rats. CoQ10 or mexicor were injected in a dose of 30 mg/kg intravenously 10 min after coronary artery occlusion. The observed cardioprotective effects of ubidecarenone and mexicor were close. Both drugs equally increased the survival of rats, prevented the development of dilatation and hypertrophy of the left ventricle, and improved the pump cardiac function. Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Male; Myocardial Infarction; Pyridines; Rats; Rats, Wistar; Ubiquinone; Vitamins	2015

Article

Year

[COMPARATIVE CARDIOPROTECTIVE EFFICACY OF COENZYME Q10 AND MEXICOR IN EXPERIMENTAL MODEL OF MYOCARDIAL INFARCTION IN RATS].

Eksperimental'naia i klinicheskaia farmakologiia, 2015, Volume: 78, Issue:6

Cardioprotective efficacy of coenzyme Q10 (CoQ10, ubidecarenone) and mexicor were evaluated on the 21st day of experimental myocardial infarction in Wistar rats. CoQ10 or mexicor were injected in a dose of 30 mg/kg intravenously 10 min after coronary artery occlusion. The observed cardioprotective effects of ubidecarenone and mexicor were close. Both drugs equally increased the survival of rats, prevented the development of dilatation and hypertrophy of the left ventricle, and improved the pump cardiac function.

Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Male; Myocardial Infarction; Pyridines; Rats; Rats, Wistar; Ubiquinone; Vitamins

2015